Development of a standardized transfusion ratio as a metric for evaluating dialysis facility anemia management practices

American Journal of Kidney Diseases

Volumn 64, Issue 4, 2014, Pages 608-615

  Liu, Jiannong ^a   Li, Suying ^a   Gilbertson, David T ^a   Monda, Keri L ^b   Bradbury, Brian D ^b   Collins, Allan J ^a,c  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b AMGEN INC   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Anemia; anemia management; Bayesian approach; dialysis; end stage renal disease (ESRD); facility level practice; standardized ratio; transfusion

Indexed keywords

ADULT; ANEMIA; ARTICLE; BAYES THEOREM; ERYTHROCYTE TRANSFUSION; EVALUATION STUDY; FEASIBILITY STUDY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; METRIC SYSTEM; STANDARDIZED TRANSFUSION RATIO; AGED; COMPLICATION; CONFIDENCE INTERVAL; DISEASE MANAGEMENT; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PROCEDURES; PUBLIC HEALTH SERVICE; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; STANDARDS; UNITED STATES;

AGED; ANEMIA; BAYES THEOREM; CONFIDENCE INTERVALS; DISEASE MANAGEMENT; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PUBLIC HEALTH PRACTICE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84908141469     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2014.04.012     Document Type: Article

References (30)

1. Kidney Disease: Improving Global Outcomes. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease Kidney Int Suppl 2 2 2012 1 335
2. J.W. Eschbach, and J.W. Adamson Anemia of end-stage renal disease (ESRD) Kidney Int 28 1 1985 1 5
3. J.W. Eschbach, M.H. Abdulhadi, and J.K. Browne Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial Ann Intern Med 111 12 1989 992 1000
4. J.W. Eschbach, M.R. Kelly, N.R. Haley, R.I. Abels, and J.W. Adamson Treatment of the anemia of progressive renal failure with recombinant human erythropoietin N Engl J Med 321 3 1989 158 163
5. A.J. Collins, R.N. Foley, and C. Herzog US Renal Data System 2012 annual data report Am J Kidney Dis 61 1 suppl 1 2013 e1 e480
6. S. Li, and A.J. Collins Association of hematocrit value with cardiovascular morbidity and mortality in incident hemodialysis patients Kidney Int 65 2 2004 626 633
7. D.L. Regidor, J.D. Kopple, and C.P. Kovesdy Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients J Am Soc Nephrol 17 4 2006 1181 1191
8. A.J. Collins, R.N. Foley, and C. Herzog US Renal Data System 2010 annual data report Am J Kidney Dis 57 1 suppl 1 2011 e1 e526
9. M.A. Pfeffer, E.A. Burdmann, and C.Y. Chen A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease N Engl J Med 361 21 2009 2019 2032
10. T.B. Drueke, F. Locatelli, and N. Clyne Normalization of hemoglobin level in patients with chronic kidney disease and anemia N Engl J Med 355 20 2006 2071 2084
11. A.K. Singh, L. Szczech, and K.L. Tang Correction of anemia with epoetin alfa in chronic kidney disease N Engl J Med 355 20 2006 2085 2098
12. A. Besarab, W.K. Bolton, and J.K. Browne The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin N Engl J Med 339 9 1998 584 590
13. Amgen Inc. Prescribing information for Epogen (epoetin alfa), supplement no. 5281. Approved May 2012. http://www.accessdata.fda.gov/drugsatfda-docs/label/2012/103234s5281lbl.pdf. 2012. Accessed February 25, 2014.
14. Department of Health and Human Services and Centers for Medicare & Medicaid Services. 42 CFR Parts 410, 413, and 414; Medicare Program; End-Stage Renal Disease Prospective Payment System; Final Rule and Proposed Rule. www.access.gpo.gov. 75(155). Accessed February 25, 2014.
15. US Government Accountability Office. End-Stage Renal Disease: Reduction in Drug Utilization Suggests Bundled Payment Is Too High. December 7, 2012. Washington, DC; 2012. http://www.gao.gov/products/GAO-13-190R. Accessed February 25, 2014.
16. Centers for Medicare & Medicaid Services. ESRD Prospective Payment System (ESRD PPS) Overview of 2011 and 2012 Claims-Based Monitoring Program. http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ESRDpayment/Spotlight.html. Accessed February 25, 2014.
17. Collins AJ. ESRD payment policy changes: the new "bundled" dialysis prospective payment system (PPS) in the United States. http://www.usrds.org/2012/pres/USDialysisBundle-impact-NKFCM2012.pdf. 2012. Accessed February 25, 2014.
18. Gilbertson DT, Collins AJ, Foley R. Transition in service utilization: vascular access, injectables, hemoglobin levels, and transfusions. www.usrds.org. 2013. Accessed February 25, 2014.
19. K.S. Gill, P. Muntner, and R.A. Lafayette Red blood cell transfusion use in patients with chronic kidney disease Nephrol Dial Transplant 28 6 2013 1504 1515
20. R.A. Wolfe The standardized mortality ratio revisited: improvements, innovations, and limitations Am J Kidney Dis 24 2 1994 290 297
21. H. Goldstein, and D. Spiegelhalter League tables and their limitations: statistical issues in comparisons of institutional performance J R Stat Soc 159 3 1996 385 443
22. C.L. Christiansen, and C.N. Morris Improving the statistical approach to health care provider profiling Ann Intern Med 127 8, pt 2 1997 764 768
23. M. McClellan, and D. Staiger The Quality of Health Care Providers. Technical report 7327 1999 National Bureau of Economic Research Cambridge, MA
24. M.B. Landrum, S.E. Bronskill, and S.T. Normand Analytic methods for constructing cross-sectional profiles of health care providers Health Serv Outcomes Res Methodol 1 1 2000 23 47
25. J. Liu, T.A. Louis, W. Pan, J.Z. Ma, and A.J. Collins Methods for estimating and interpreting provider-specific standardized mortality ratios Health Serv Outcomes Res Methodol 4 3 2003 135 149
26. Arbor Research Collaborative for Health and the University of Michigan Kidney Epidemiology and Cost Center (KECC). End-stage renal disease (ESRD) quality measures. http://www.dialysisreports.org/. Accessed February 25, 2014.
27. SRTR Transplant Center Locator. Scientific Registry of Transplant Recipients. http://www.srtr.org/csr/current/Centers/Default.aspx. 2013. Accessed February 25, 2014.
28. A. Kruse, D.E. Uehlinger, F. Gotch, P. Kotanko, and N.W. Levin Red blood cell lifespan, erythropoiesis and hemoglobin control Contrib Nephrol 161 2008 247 254
29. H.N. Ibrahim, A. Ishani, R.N. Foley, H. Guo, J. Liu, and A.J. Collins Temporal trends in red blood transfusion among US dialysis patients, 1992-2005 Am J Kidney Dis 52 6 2008 1115 1121
30. D.T. Gilbertson, K.L. Monda, B.D. Bradbury, and A.J. Collins RBC transfusions among hemodialysis patients (1999-2010): influence of hemoglobin concentrations below 10 g/dL Am J Kidney Dis 62 5 2013 919 928